1. Home
  2. ADXN vs ICCT Comparison

ADXN vs ICCT Comparison

Compare ADXN & ICCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADXN
  • ICCT
  • Stock Information
  • Founded
  • ADXN 2002
  • ICCT 1992
  • Country
  • ADXN Switzerland
  • ICCT United States
  • Employees
  • ADXN N/A
  • ICCT N/A
  • Industry
  • ADXN Biotechnology: Pharmaceutical Preparations
  • ICCT Computer Software: Prepackaged Software
  • Sector
  • ADXN Health Care
  • ICCT Technology
  • Exchange
  • ADXN Nasdaq
  • ICCT Nasdaq
  • Market Cap
  • ADXN 8.9M
  • ICCT 9.1M
  • IPO Year
  • ADXN N/A
  • ICCT N/A
  • Fundamental
  • Price
  • ADXN $8.30
  • ICCT $0.86
  • Analyst Decision
  • ADXN
  • ICCT
  • Analyst Count
  • ADXN 0
  • ICCT 0
  • Target Price
  • ADXN N/A
  • ICCT N/A
  • AVG Volume (30 Days)
  • ADXN 2.2K
  • ICCT 27.5K
  • Earning Date
  • ADXN 08-08-2024
  • ICCT 08-08-2024
  • Dividend Yield
  • ADXN N/A
  • ICCT N/A
  • EPS Growth
  • ADXN N/A
  • ICCT N/A
  • EPS
  • ADXN N/A
  • ICCT N/A
  • Revenue
  • ADXN $1,568,105.00
  • ICCT $9,034,579.00
  • Revenue This Year
  • ADXN N/A
  • ICCT N/A
  • Revenue Next Year
  • ADXN N/A
  • ICCT N/A
  • P/E Ratio
  • ADXN N/A
  • ICCT N/A
  • Revenue Growth
  • ADXN N/A
  • ICCT 16.06
  • 52 Week Low
  • ADXN $5.00
  • ICCT $0.81
  • 52 Week High
  • ADXN $27.90
  • ICCT $10.60
  • Technical
  • Relative Strength Index (RSI)
  • ADXN 46.05
  • ICCT 43.97
  • Support Level
  • ADXN $8.10
  • ICCT $0.81
  • Resistance Level
  • ADXN $8.40
  • ICCT $0.93
  • Average True Range (ATR)
  • ADXN 0.20
  • ICCT 0.06
  • MACD
  • ADXN 0.13
  • ICCT 0.00
  • Stochastic Oscillator
  • ADXN 61.86
  • ICCT 41.60

About ADXN Addex Therapeutics Ltd

Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.

About ICCT iCoreConnect Inc. Common stock

iCoreConnect Inc develops and markets secure cloud-based HIPAA compliant software services focused on compliance, workflow/productivity, and electronic health records systems. Its core services technology can be adopted to other vertical markets that require a high degree of secure data communication, such as the legal, financial, and education fields. It markets secure HIPAA compliant cloud-based software as a service (SaaS) offering under the names of iCoreExchange, iCoreCodeGenius, iCoreSecure, iCoreMD, iCoreDental, iCoreMobile, iCoreHuddle, iCoreRx, iCorePDMP, iCoreEPCS, and iCorePay. The company's software is sold under annual recurring revenue subscriptions. The company has a single reporting segment for reporting purposes focused on the North American market.

Share on Social Networks: